Search Results - "Kably, Benjamin"

Refine Results
  1. 1

    Antifungal Drugs TDM: Trends and Update by Kably, Benjamin, Launay, Manon, Derobertmasure, Audrey, Lefeuvre, Sandrine, Dannaoui, Eric, Billaud, Eliane M.

    Published in Therapeutic drug monitoring (01-02-2022)
    “…The increasing burden of invasive fungal infections results in growing challenges to antifungal (AF) therapeutic drug monitoring (TDM). This review aims to…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Dried Urine Spot Analysis for assessing cardiovascular drugs exposure applicable in spaceflight conditions by Derobertmasure, Audrey, Kably, Benjamin, Justin, Junior, De Sousa Carvalho, Christelle, Billaud, Eliane M., Boutouyrie, Pierre

    “…•Dried urine spot as an alternative to urine sampling in extreme conditions particularly during spaceflight missions.•A method was developed to detect 5…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Loading Dose of Ceftazidime Needs to Be Increased in Critically Ill Patients: A Retrospective Study to Evaluate Recommended Loading Dose with Pharmacokinetic Modelling by Launay, Manon, Ollier, Edouard, Kably, Benjamin, Le Louedec, Félicien, Thiery, Guillaume, Lanoiselée, Julien, Perinel-Ragey, Sophie

    Published in Antibiotics (Basel) (11-08-2024)
    “…To rapidly achieve ceftazidime target concentrations, a 2 g loading dose (LD) is recommended before continuous infusion, but its adequacy in critically ill…”
    Get full text
    Journal Article
  6. 6

    Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study by Mimram, Léo, Magréault, Sophie, Kerroumi, Younes, Salmon, Dominique, Kably, Benjamin, Marmor, Simon, Jannot, Anne-Sophie, Jullien, Vincent, Zeller, Valérie

    Published in Antibiotics (Basel) (01-11-2022)
    “…A population PK model of clindamycin orally administered to patients with prosthetic joint infections (PJIs) was developed using NONMEM 7.5. Monte-Carlo…”
    Get full text
    Journal Article
  7. 7

    EFFICACY OF ULTRASOUND RENAL DENERVATION BASED UPON CHANGES IN DETECTED ANTIHYPERTENSIVE MEDICATIONS WITHIN THE RADIANCE HTN-TRIO STUDY by Zeijen, Victor J. M., Azizi, Michel, Kirtane, Ajay J., Kably, Benjamin, Daemen, Joost

    Published in Journal of hypertension (01-05-2024)
    “…Objective: The randomized RADIANCE-HTN TRIO trial assessed the safety and efficacy of ultrasound renal denervation (uRDN) among patients with resistant…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Urine N-acetyl-Ser-Asp-Lys-Pro measurement as a versatile biomarker to assess adherence to angiotensin-converting enzyme inhibitors by Kably, Benjamin, Billaud, Eliane M., Derobertmasure, Audrey, Blanchard, Anne, Boutouyrie, Pierre, Azizi, Michel

    Published in Journal of hypertension (01-02-2022)
    “…Poor adherence to treatment is a major health issue in hypertension. The large number of drugs to be detected limits the implementation of chemical adherence…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Belatacept‐based immunosuppression: A calcineurin inhibitor‐sparing regimen in heart transplant recipients by Launay, Manon, Guitard, Joelle, Dorent, Richard, Prevot, Yoann, Prion, Florent, Beaumont, Laurence, Kably, Benjamin, Lecuyer, Lucien, Billaud, Eliane M., Guillemain, Romain

    Published in American journal of transplantation (01-02-2020)
    “…Belatacept (BTC) is indicated for prophylaxis of graft rejection in adults receiving a renal transplant (Tx). This retrospective observational study (three…”
    Get full text
    Journal Article
  16. 16

    Is there any Hope for Monitoring Adherence in an Efficient and Feasible Way for Resistant Hypertension Diagnosis and Follow-Up? by Kably, Benjamin, Billaud, Eliane M., Boutouyrie, Pierre, Azizi, Michel

    Published in Current hypertension reports (01-11-2020)
    “…Purpose of Review Non-adherence to antihypertensive treatment is highly prevalent and represents a major factor affecting their effectiveness in hypertensive…”
    Get full text
    Journal Article
  17. 17

    IMPLEMENTATION OF URINARY DRUG DETECTION FOR ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE DRUGS IN DAY-TO-DAY CARE IN A TERTIARY HYPERTENSION CLINIC IN PARIS AREA by Kably, Benjamin, Billaud, Eliane M, Belmihoub, Ines, Madjalian, Anne-Marie, Lorthioir, Aurélien, Amar, Laurence, Boutouyrie, Pierre, Azizi, Michel

    Published in Journal of hypertension (01-04-2021)
    “…Objective: Non-adherence to antihypertensive drug (AHD) therapy is a major health challenge contributing to uncontrolled/resistant hypertension and major…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin by Gras, Emmanuelle, Tran, Yohann, Kably, Benjamin, Lillo-Lelouet, Agnès, Caruba, Thibaut, Sabatier, Brigitte, Launay, Manon, Billaud, Eliane, Smadja, David M., Gendron, Nicolas, Lebeaux, David

    Published in Infection (01-04-2024)
    “…Purpose Major bleedings have been described with cefazolin. The objective was to determine the frequency of bleeding events in cefazolin-treated patients and…”
    Get full text
    Journal Article